UNSPSC 51284109: Cefotaxime

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N2GI8B1GK7. European Medicines Agency schedules Cefotaxime in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07405MIG. Cefotaxime generally arises in the molecular formula C16H17N5O7S2.

UNSPSC 51284109 Cefotaxime, a Commodity code, covers pharmaceutical products procured by state and local health agencies, though recent opportunities under this code show substantial mismatch between the code's nominal scope and actual solicitation activity. State and local governments posting opportunities tagged to this code are actually buying broad categories of medical supplies, naloxone, pharmaceutical manufacturing services, and OTC products rather than cefotaxime specifically. Issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), municipal fire departments (City of Tampa), and state-level cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving multiple states including Oregon). The mix reflects both single-jurisdiction buys and multi-state cooperative purchasing vehicles designed to aggregate demand across numerous participating state and local government facilities.

Recent opportunities span Florida, Texas, Minnesota, and Oregon. Representative solicitations include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (due July 26, 2023, though posting date of June 30, 2026 suggests a data inconsistency in the source), the Texas HHS Commission's RFI on direct-to-manufacturer prescription programs (response deadline April 3, 2026), the City of Tampa's sealed-bid procurement for 169 line items of medical and first aid supplies estimated at $700,000 for the Tampa Fire Department Rescue Division (due March 13, 2026, with a certified Small Local Business Enterprise set-aside and 5% bid discount), and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers (due March 26, 2026, with July 1, 2026 contract effective date). The code shows active procurement volume but limited commodity focus — pursuit viability depends on capability to supply within specific authorized distribution networks or to meet municipal emergency-response supply chains rather than cefotaxime as a standalone pharmaceutical product.